Synthetic Peptides Identify Promiscuous Human Th1 Cell Epitopes of the Secreted Mycobacterial Antigen MPB70

ABSTRACT MPB70 is a secreted protein of Mycobacterium bovis and Mycobacterium tuberculosis which stimulates both cellular and humoral immune responses during infection with bovine and human tubercle bacilli. In addition, vaccination with MPB70 has been shown to induce Th1 cell responses and protection in animal models of tuberculosis. The present study was carried out to map the dominant human Th1 cell epitopes of MPB70 in relation to major histocompatibility complex (MHC) class II restriction in healthy subjects showing strong T-cell responses to complex mycobacterial antigens. Peripheral blood mononuclear cells (PBMC) from HLA-DR-typed donors were tested with complex mycobacterial antigens (whole-cell M. tuberculosis and M. tuberculosis culture filtrates), with MPB70 purified from the culture filtrate of M. bovis BCG Tokyo, and with 13 synthetic peptides (25-mers overlapping by 10 residues) covering the sequence of MPB70. The donors that responded to the complex antigens and MPB70 also responded to the cocktail of synthetic MPB70 peptides. Testing of PBMC with individual peptides showed that peptides p5 (amino acids [aa] 61 to 85), p6 (aa 76 to 100), p8 (aa 106 to 130), p12 (aa 166 to 190), and p13 (aa 181 to 193) were most frequently recognized in proliferation and gamma interferon (IFN-γ) assays. Testing of antigen-specific CD4+ T-cell lines with the individual peptides of MPB70 confirmed that peptides p8, p12, and p13 contain immunodominant Th1 cell epitopes of MPB70. MHC restriction analysis with HLA-typed donors showed that MPB70 and its immunodominant peptides were presented to T cells promiscuously. The T-cell lines responding to MPB70 and peptides p8, p12, and p13 in IFN-γ assays mediated antigen-peptide-specific cytotoxic activity against monocytes/macrophages pulsed with the whole-protein antigen or the peptides. In conclusion, the promiscuous recognition of MPB70 and its immunodominant peptide defined epitopes (aa 106 to 130 and 166 to 193) by IFN-γ-producing Th1 cells supports possible application of this secreted antigen to subunit vaccine design.

[1]  Andersen,et al.  Comparison of Antigen‐Specific T‐Cell Responses of Tuberculosis Patients using Complex or Single Antigens of Mycobacterium tuberculosis , 1998, Scandinavian journal of immunology.

[2]  K. Lundin,et al.  HLA‐DR4‐restricted T‐cell epitopes from the mycobacterial 60 000 MW heat shock protein (hsp 60) do not map to the sequence homology regions with the human hsp 60 , 1996, Immunology.

[3]  T. Godal,et al.  In vitro induction of human suppressor T cells by mycobacterial antigens. BCG activated OKT4+ cells mediate suppression of antigen induced T cell proliferation. , 1983, Clinical and Experimental Immunology.

[4]  H. Vordermeier,et al.  Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guérin vaccination in cattle. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  A. Mustafa.  Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. , 1996, International journal of leprosy and other mycobacterial diseases.

[6]  T. Godal,et al.  BCG induced CD4+ cytotoxic T cells from BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro. , 1987, Clinical and experimental immunology.

[7]  P. Andersen.  Host Responses and Antigens Involved in Protective Immunity to Mycobacterium tuberculosis , 1997, Scandinavian journal of immunology.

[8]  K. Lundin,et al.  Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae , 1993, Infection and immunity.

[9]  T. Ottenhoff,et al.  Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. , 2000, The Journal of infectious diseases.

[10]  K. Lukacs,et al.  Protection against Mycobacterium tuberculosisInfection by CD8+ T Cells Requires the Production of Gamma Interferon , 1998, Infection and Immunity.

[11]  S. Haga,et al.  Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70 , 1983, Infection and immunity.

[12]  Zhu,et al.  38 000 MW antigen‐specific major histocompatibility complex class I restricted interferon‐γ‐secreting CD8+ T cells in healthy contacts of tuberculosis , 1998, Immunology.

[13]  F. Oftung,et al.  Characteristics of human T-cell clones from BCG and killedM. lepraevaccinated subjects and tuberculosis patients , 1986 .

[14]  N. Ohara,et al.  Cloning and Sequencing of a Unique Antigen MPT70 from Mycobacterium tuberculosis H37Rv and Expression in BCG Using E. coli‐Mycobacteria Shuttle Vector , 1995, Scandinavian journal of immunology.

[15]  M. Levin,et al.  Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. , 2000, The Journal of infectious diseases.

[16]  R. Houghten,et al.  Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells. , 1988, Journal of immunology.

[17]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[18]  J. Flynn,et al.  CD4+ T Cells Are Required for the Development of Cytotoxic CD8+ T Cells During Mycobacterium tuberculosis Infection1 , 2001, The Journal of Immunology.

[19]  K. Lundin,et al.  Primary Structure and MHC Restriction of Peptide-Defined T Cell Epitopes from Recombinant Mycobacterial Protein Antigens , 1997 .

[20]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[21]  J. Deeks,et al.  Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells , 2001, The Lancet.

[22]  J. Matsumoto,et al.  Specific skin-reactive protein from culture filtrate of Mycobacterium bovis BCG , 1981, Infection and immunity.

[23]  K. Lundin,et al.  Heterogeneity among human T cell clones recognizing an HLA-DR4,Dw4-restricted epitope from the 18-kDa antigen of Mycobacterium leprae defined by synthetic peptides. , 1990, Journal of Immunology.

[24]  K. Lundin,et al.  Identification and HLA Restriction of Naturally Derived Th1-Cell Epitopes from the Secreted Mycobacterium tuberculosisAntigen 85B Recognized by Antigen-Specific Human CD4+T-Cell Lines , 2000, Infection and Immunity.

[25]  H. Billman-Jacobe,et al.  Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis. , 1994, The Journal of infectious diseases.

[26]  T. Ottenhoff,et al.  Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1‐like cytokine secretion profile: Heterogeneity in cytotoxic activity and cytokine secretion levels , 1993, European journal of immunology.

[27]  M. Torres,et al.  Cytokine Profiles for Peripheral Blood Lymphocytes from Patients with Active Pulmonary Tuberculosis and Healthy Household Contacts in Response to the 30-Kilodalton Antigen ofMycobacterium tuberculosis , 1998, Infection and Immunity.

[28]  K. Lundin,et al.  An HLA-DRw53-restricted T-cell epitope from a novel Mycobacterium leprae protein antigen important to the human memory T-cell repertoire against M. leprae , 1994, Infection and immunity.

[29]  J. Abrams,et al.  Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.

[30]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[31]  H. Wiker,et al.  Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis , 1991, Infection and immunity.

[32]  A. Sette,et al.  Differential effects of cytolytic T cell subsets on intracellular infection. , 1997, Science.

[33]  P. Andersen,et al.  Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT‐6 antigen , 2000, European journal of immunology.

[34]  J. Pollock,et al.  Identification of bovine T-cell epitopes for three Mycobacterium bovis antigens: MPB70, 19,000 MW and MPB57. , 1994, Immunology.

[35]  M. Bonneville,et al.  Vγ9 / Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis , 2000 .

[36]  M. Harboe,et al.  MPB70, a unique antigen of Mycobacterium bovis BCG. , 1984, The American review of respiratory disease.

[37]  R. Wilkinson,et al.  High frequencies of circulating IFN‐γ‐secreting CD8 cytotoxic T cells specific for a novel MHC class I‐restricted Mycobacterium tuberculosis epitope in M. tuberculosis‐infected subjects without disease , 2000 .

[38]  F. Oftung,et al.  Characteristics of human T-cell clones from BCG and killed M. leprae vaccinated subjects and tuberculosis patients. Recognition of recombinant mycobacterial antigens. , 1986, Leprosy Review.

[39]  P. Dierckx,et al.  Specific Lymphoproliferation, Gamma Interferon Production, and Serum Immunoglobulin G Directed against a Purified 32 kDa Mycobacterial Protein Antigen (P32) in Patients with Active Tuberculosis , 1988, Scandinavian journal of immunology.

[40]  H. Billman-Jacobe,et al.  Mapping of the T and B cell epitopes of the Mycobacterium bovis protein, MPB70 , 1990, Immunology and cell biology.

[41]  H. Vordermeier,et al.  Development of Diagnostic Reagents To Differentiate between Mycobacterium bovis BCG Vaccination and M. bovis Infection in Cattle , 1999, Clinical Diagnostic Laboratory Immunology.

[42]  Pollock,et al.  T‐Cell Recognition of Mycobacterial Proteins MPB70 and MPB64 in Cattle Immunized with Antigen and Infected with Mycobacterium bovis , 1998, Scandinavian journal of immunology.

[43]  H. Mollenkopf,et al.  Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors , 1998, European journal of immunology.

[44]  A. Mustafa,et al.  HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae. , 1989, International journal of leprosy and other mycobacterial diseases.

[45]  P. E. M. Fine,et al.  Variation in protection by BCG: implications of and for heterologous immunity , 1995, The Lancet.

[46]  H. Wiker,et al.  Protein G-based enzyme-linked immunosorbent assay for anti-MPB70 antibodies in bovine tuberculosis , 1990, Journal of clinical microbiology.

[47]  T. Yamada,et al.  Complete nucleotide sequence of immunogenic protein MPB70 from Mycobacterium bovis BCG. , 1989, FEMS microbiology letters.

[48]  N. Kudeken,et al.  [A therapeutic trial of experimental tuberculosis with gamma-interferon in an immunocompromised mouse model]. , 1994, Kekkaku : [Tuberculosis].

[49]  A. Mustafa.  Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. , 2001, Current pharmaceutical biotechnology.

[50]  H. Vordermeier,et al.  Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle , 2002, Clinical and experimental immunology.

[51]  T. Eguale,et al.  Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. , 1999, The Journal of infectious diseases.

[52]  M. Gennaro,et al.  Immunochemical Characterization of the MPB70/80 and MPB83 Proteins of Mycobacterium bovis , 1998, Infection and Immunity.

[53]  T. Ottenhoff,et al.  Mapping of multiple HLA class II-restricted T-cell epitopes of the mycobacterial 70-kilodalton heat shock protein , 1994, Infection and immunity.

[54]  G. Kvalheim,et al.  Mycobacterial crossreactivity of M. tuberculosis reactive T cell clones from naturally converted PPD positive healthy subjects. , 1998, FEMS immunology and medical microbiology.

[55]  A. Mustafa.  Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w. , 1988, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[56]  K. Lundin,et al.  Identification of Promiscuous Epitopes from the Mycobacterial 65-Kilodalton Heat Shock Protein Recognized by Human CD4+ T Cells of the Mycobacterium lepraeMemory Repertoire , 1999, Infection and Immunity.

[57]  J. Abrams,et al.  Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. , 1993, Journal of immunology.

[58]  O. Olerup,et al.  DR "low-resolution" PCR-SSP typing--a correction and an up-date. , 1993, Tissue antigens.

[59]  A. Hill,et al.  Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. , 2001, The Journal of infectious diseases.

[60]  K. Hasløv,et al.  Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[61]  T. Hansen,et al.  Pathway of propionate degradation in Desulfobulbus propionicus , 1988 .

[62]  T. Lea,et al.  T‐ and B‐Cell Epitopes in the Secreted Mycobacterium bovis Antigen MPB70 in Mice , 2003, Scandinavian journal of immunology.